Opioid Manufacturer Indivior ’s Chief Executive Officer Pleads Guilty in Connection with Drug Safety Claims

July 3, 2020

FDA OCI, Shaun Thaxter, CEO, Indivior, guilty plea, opioid, Suboxone Film, misbranded, Reckitt Benckiser, recovery, addicts, marketing, withdrawal, treatment, buprenorphine, sales, preferred drug status, false information, misleading information (Source: Office of Criminal Investigations (OCI) Press Releases) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social […]

Read the full article →

Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder – Peckham AD, Griffin ML, McHugh RK, Weiss RD.

June 25, 2020

BACKGROUND: In the multi-site Prescription Opioid Addiction Treatment Study (POATS), the best predictor of successful opioid use outcome was lifetime diagnosis of major depressive disorder. The primary aim of this secondary analysis of data from POATS was … (Source: SafetyLit) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log […]

Read the full article →

Indivior shares rise as it boosts guidance for a second time

June 17, 2020

Drugmaker lifted by strong performance of opioid treatment Suboxone (Source: FT.com – Drugs and Healthcare) MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

Read the full article →

Embattled drugmaker Indivior raises forecasts on Suboxone strength

June 17, 2020

Indivior Plc on Tuesday raised its full-year forecasts as the embattled British drugmaker’s best-selling opioid addiction drug Suboxone fared better than expected in the face of competition from copycats. (Source: Reuters: Health)

Read the full article →

Association between buprenorphine/naloxone and high-dose opioid analgesic prescribing in Kentucky, 2012-2017 – Luu H, Slavova S, Freeman PR, Lofwall M, Browning S, Slade E, Bush H.

June 17, 2020

INTRODUCTION: Buprenorphine/naloxone treatment is a highly effective treatment for opioid use disorder decreasing illicit opioid use and both all-cause and opioid-involved overdose mortality. The purpose of this study was to investigate the relationships b… (Source: SafetyLit)

Read the full article →

Five Pennsylvania Physicians Charged with Unlawfully Distributing Buprenorphine and Defrauding Medicare and Medicaid

June 17, 2020

opioid addiction treatment, Krishan Kumar Aggarwal, Moon Township PA, RTA, Weirton WV, Madhu Aggarwal, Bridgeville PA, Parth Bharill, Pittsburgh PA, Cherian John, Coraopolis PA, Weirton WV, Michael Bummer, Sewickley PA, Suboxone, buprenorphine, Subutex, Redirections Treatment Advocates, (Source: Office of Criminal Investigations (OCI) Press Releases)

Read the full article →

Willingness to take buprenorphine/naloxone among people who use opioids in Vancouver, Canada – Weicker SA, Hayashi K, Grant C, Milloy MJ, Wood E, Kerr T.

June 17, 2020

OBJECTIVES: Opioid agonist therapy is the cornerstone of treatment of opioid use disorder. In Canada, buprenorphine/naloxone has recently been adopted as the first line agonist therapy given its comparable effectiveness to methadone and superior safety pro… (Source: SafetyLit)

Read the full article →

Baymark Health Services Acquires Two Suboxone Clinics In Louisiana

June 17, 2020

BayMark brand AppleGate Recovery expands footprint and enhances opioid addiction treatment services.(PRWeb May 15, 2020)Read the full story at https://www.prweb.com/releases/baymark_health_services_acquires_two_suboxone_clinics_in_louisiana/prweb17124788.htm (Source: PRWeb: Medical Pharmaceuticals) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

Justice Department Obtains $1.4 Billion from Reckitt Benckiser Group in Largest Recovery in a Case Concerning an Opioid Drug in United States History

August 9, 2019

Suboxone, recovering opioid addicts, withdrawal symptoms, buprenorphine, Individor, Suboxone Film, Here to Help, discontinuance of tablet Suboxone, (Source: Office of Criminal Investigations (OCI) Press Releases) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

MedicaSafe Turns Attention to Opioid Addiction

July 21, 2019

One of MedicaSafe’s primary goals is to develop products for high-risk medication management. So it makes sense for the New York-based company to focus on opioid addiction, which claims the lives of more than 130 people every day in the U.S. (According to the U.S. Department of Health and Human Services). The New York-based company […]

Read the full article →

← Previous Entries

Next Entries →